DNA Markets Review

When FXCanary sets out to assess a broker, our editorial team digs far beyond the promotional materials. For DNA Markets, we cross-checked the broker’s ASIC licence against the public register, scrutinised the fine print of its client agreement, and compiled every available real user review across Trustpilot, Forex Peace Army, and leading industry databases. We also searched for clone sites, scam alerts, and regulatory warnings.

Our investigation incorporated both quantitative signals – including a 35/100 Scam Risk Score, 3 withdrawal complaints, and a confirmed clone website – and a qualitative reading of the 18 Trustpilot reviews, which revealed a stark split between enthusiastic praise and deeply troubling disclosures. This review presents our findings in full transparency, so you can decide whether DNA Markets meets your safety and trading standards.

DNA Markets is traded under the legal name Focus Markets Pty Ltd, a company registered at an iconic Melbourne skyscraper, South Tower Level 35, 525 Collins Street. Officially, the brokerage was founded on 29 November 2022 and began serving clients in 2023. With a polished website and a narrative of Australian innovation, the broker initially projects an image of a well-capitalised, regulated player.

However, a deeper dive raises immediate questions. The company’s profile shows 0 employees listed – a peculiar figure for an operating brokerage, though it could reflect a structure relying heavily on outsourced services. More importantly, FXCanary’s analysis of user disclosures and the client agreement exposes a dual-entity setup: while Focus Markets Pty Ltd holds the ASIC licence, many client accounts are actually held under Focus Markets LLC, a company incorporated in Saint Vincent and the Grenadines (SVG). SVG is a well-known offshore jurisdiction with virtually no financial oversight or investor protection. This structural bifurcation is a critical fact that every potential client must understand, as it significantly alters the risk profile.

DNA Markets’ primary regulatory credential is Australian Financial Services Licence No. 514425, issued by ASIC. ASIC is a Tier-1 regulator that enforces strict capital adequacy, professional indemnity insurance, and client money segregation rules. For Australian residents, trading under this licence offers a reasonable degree of confidence – though it’s worth noting that ASIC does not provide a compensation fund like the UK’s FSCS; in the event of insolvency, clients would be classified as unsecured creditors.

For international clients, the situation is far murkier. By routing account agreements through Focus Markets LLC in SVG, DNA Markets effectively places those traders outside ASIC’s protective umbrella. An SVG International Business Company (IBC) is not authorised to conduct financial services in any reputable jurisdiction and is not subject to meaningful oversight.

This practice, while legal in a technical sense, is commonly exploited by brokers who wish to offer higher leverage or bypass client fund protections. FXCanary views this offshore layer as a significant red flag. A broker that genuinely prioritizes client safety would not need to employ such a structure.

DNA Markets does not publish a straightforward fee schedule or detailed comparison of account tiers on its website. From aggregated industry data and user reports, we understand that the broker offers at least two account classifications: a standard commission-free account and a raw spread account with a commission per lot. The raw spread account is heavily promoted, with claims of zero spread on EURUSD and GBPUSD, making it particularly appealing to scalpers and algorithmic traders.

The minimum deposit is not clearly advertised, but user accounts suggest that modest sums are accepted. Leverage offerings are equally opaque; under the ASIC-regulated entity, retail clients are capped at 1:30 for major forex pairs, but through the SVG entity, higher leverage may be available – a setup that imposes asymmetric risk on those using the offshore arm. FXCanary recommends that traders demand explicit written confirmation of which entity will hold their account before funding, as the legal protections differ drastically.

Our review of user feedback paints a mixed but concerning picture. On the positive side, several traders recount smooth deposits and quick withdrawals; one user described the process as ‘easy and done quickly’. DNA Markets supports common payment methods, and funds are meant to be segregated at Australian banks for ASIC-regulated accounts.

However, the three withdrawal-related complaints we identified align with more serious allegations. One customer, Margarita (account 1000355), publicly asked the company to ‘withdraw my money’, indicating a stalled or refused withdrawal. Another 1-star review explicitly accuses the broker of failing to process withdrawals through the original deposit method, a practice that would contravene anti-money laundering norms.

Even more alarming is the user who claimed that after withdrawing, they ‘did not get my complete amount’. These incidents, while not necessarily universal, are consistent with a broker that may impose unexpected hurdles when clients request their funds. FXCanary advises caution: never commit more capital than you can afford to lose to any broker with a history of unresolved withdrawal grievances.

DNA Markets claims access to over 800 financial instruments, covering forex, commodities, indices, shares, and cryptocurrencies. Trading is exclusively supported on MetaTrader 5, which is a robust, industry-standard platform suitable for both manual and automated strategies. User reviews confirm that the MT5 implementation is stable, with no reported crashes or widespread technical glitches.

That said, the client dashboard – the web-based portal for account management – drew mild criticism for feeling ‘dated’ compared to newer competitors. While this is not a dealbreaker, it suggests that the broker’s technology investment may lag behind its marketing. Instrument diversity is adequate, though not exceptional; it meets the needs of most retail traders but doesn’t differentiate the broker in a crowded market.

One of DNA Markets’ strongest selling points is its tight spread environment. Multiple users report experiencing no spread on EURUSD and GBPUSD at certain times, alongside generally competitive pricing during normal market hours. This is a genuine advantage for cost-sensitive strategies.

Yet, the picture is not uniformly rosy. A handful of reviews note that spreads can ‘jump a bit during the rollover period’ and, more critically, that spreads rise upon order placement – a tactic sometimes used by market-making brokers to increase transaction costs. Additionally, a user complained of suspicious price spikes at every stop-loss, intentionally triggering stops and magnifying losses.

If true, this would indicate a conflict of interest under the market maker model. DNA Markets’ ASIC licence permits a Market Making (MM) designation, meaning it acts as the direct counterparty to client trades. In such a setup, the broker profits when clients lose, creating an inherent incentive imbalance.

Traders should monitor their execution quality closely and compare with independent data feeds.

We aggregated 18 Trustpilot reviews and supplemented them with trader forum posts and complaint data. The feedback splits into three categories.

First, a cohort of enthusiastic users who praise ‘instant execution’, ‘very fast response’ from support, and spreads so tight that one reviewer called DNA Markets ‘literally the only firm with no spreads on eurusd and gbpusd’. These users, often with short track records, seem genuinely satisfied.

Second, a smaller but vocal group reporting operational nuisances: a dashboard that feels old, spreads that widen during rollover, and occasional support inexperience. While annoying, these issues are not uncommon among neobrokers.

The third and most alarming group consists of users who have taken the time to read the client agreement or have experienced abrupt account actions. One reviewer, in a 1-star post, stated that DNA Markets confirmed in writing that client accounts are held under Focus Markets LLC in SVG. This user explicitly asked about the implications and received a dismissive response referencing clause 23.3 of the agreement. Another 2-star review describes accounts being closed without warning. These narratives, combined with the withdrawal complaints, paint a picture of a broker that may be using its ASIC licence as a marketing veneer while routing the actual client relationship through an unregulated entity.

DNA Markets holds a 3.5/5 Trustpilot average over 18 reviews, a score that appears middling but masks the polarization. Forex Peace Army lists no reviews, which is unusual and may indicate a lack of community engagement on that platform. In industry databases, the broker’s profile reveals 3 withdrawal-related complaints and 1 confirmed clone/impersonator website – a site that mimics DNA Markets to defraud unsuspecting traders. This impostor site adds a layer of external risk, as clients must ensure they are dealing with the genuine broker.

Our FXCanary Scam Risk Score of 35/100 places DNA Markets firmly in the ‘Guarded’ category. This score reflects elevated risk due to the offshore entity structure, withdrawal disputes, clone site presence, and the inherent conflicts of the market maker model. It is not a declaration of fraud, but a clear warning that due diligence is insufficient for peace of mind.

DNA Markets presents a classic case of a broker with attractive surface features – razor-thin spreads, fast MT5 execution – concealing a more problematic corporate architecture. For a trader who understands that their account will legally reside with a Vincentian LLC and not the ASIC-regulated Australian entity, and who accepts the market maker conflict, the broker’s low costs could be worthwhile. However, for the vast majority of retail traders, the risks are too high.

The documented withdrawal problems, the absence of any meaningful investor compensation, and the deliberate use of an offshore entity to conduct brokerage services are red flags that align with many past broker collapses. FXCanary recommends that anyone considering DNA Markets request a written statement confirming the exact legal entity that will hold their funds, and test the withdrawal process with a small amount early in the relationship. Even then, keep exposure minimal. There are dozens of brokers with genuinely strong regulatory frameworks that offer competitive spreads; the marginal cost saving here is not worth the potential loss of capital.